Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s stock price hit a new 52-week high on Tuesday. The stock traded as high as $10.59 and last traded at $10.59, with a volume of 187 shares traded. The stock had previously closed at $10.58.
Aspen Pharmacare Stock Performance
The company has a current ratio of 2.54, a quick ratio of 1.68 and a debt-to-equity ratio of 0.12. The business’s 50-day simple moving average is $9.78 and its 200-day simple moving average is $8.79.
Aspen Pharmacare Company Profile
Aspen Pharmacare is a South African pharmaceutical company headquartered in Durban. Founded in 1997, it develops, manufactures and markets branded and generic medicines for patients and healthcare providers. The company’s product portfolio includes prescription and over-the-counter medicines across a range of therapeutic areas, as well as specialized products such as injectable medicines, anesthetics and treatments for thrombosis. Aspen also operates pharmaceutical manufacturing facilities and supplies medicines to other companies and healthcare markets.
Further Reading
- Five stocks we like better than Aspen Pharmacare
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
- Tyson Foods’ Earnings Beat Hides a Warning for Consumer Staples Dividend Investors
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
